CUFinder

Timothy Owen

Timothy Owen

Queens University

H-index: 10

Asia-Bangladesh

Contact Timothy Owen

About Timothy Owen

Timothy Owen, With an exceptional h-index of 10 and a recent h-index of 9 (since 2020), a distinguished researcher at Queens University, specializes in the field of Radiation Oncology, Breast Cancer, Lung Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

The Management of Stage I Non-Small Cell Lung Cancer (NSCLC) in Ontario: A Population-Based Study of Patterns of Care and Stereotactic Ablative Body Radiotherapy (SABR …

Long-Term Toxicity in Patients Receiving Radiotherapy for Ultracentral Stage I Non-Small Cell Lung Cancer–A Secondary Analysis of the LUSTRE Randomized Trial

PO-1332 Risk factors for intracranial metastasis in stage III NSCLC after chemoradiation

Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer …

Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation

LUSTRE: a phase III randomized trial of stereotactic body radiotherapy (SBRT) vs. conventionally hypofractionated radiotherapy (CRT) for medically inoperable stage I non-small …

Combination Intravenous Immune Globulin (IVIG) and High Dose Steroids for Treatment of Immune-Related Myelitis in a Non-Small Cell Lung Cancer Patient Treated With …

Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial

Timothy Owen Information

University

Position

___

Citations(all)

187

Citations(since 2020)

140

Cited By

81

hIndex(all)

10

hIndex(since 2020)

9

i10Index(all)

10

i10Index(since 2020)

9

Email

University Profile Page

Google Scholar

Timothy Owen Skills & Research Interests

Radiation Oncology

Breast Cancer

Lung Cancer

Top articles of Timothy Owen

The Management of Stage I Non-Small Cell Lung Cancer (NSCLC) in Ontario: A Population-Based Study of Patterns of Care and Stereotactic Ablative Body Radiotherapy (SABR …

Radiotherapy and Oncology

2024/2/15

Timothy Owen
Timothy Owen

H-Index: 6

Long-Term Toxicity in Patients Receiving Radiotherapy for Ultracentral Stage I Non-Small Cell Lung Cancer–A Secondary Analysis of the LUSTRE Randomized Trial

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

Sameer Parpia
Sameer Parpia

H-Index: 19

Harold Lau
Harold Lau

H-Index: 21

Sergio Faria
Sergio Faria

H-Index: 4

PO-1332 Risk factors for intracranial metastasis in stage III NSCLC after chemoradiation

Radiotherapy and Oncology

2023/5/1

Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer …

Cancer Treatment and Research Communications

2023/1/1

Andrew Robinson
Andrew Robinson

H-Index: 23

Timothy Owen
Timothy Owen

H-Index: 6

Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation

Liver Transplantation

2022/12

Takahiro Ito
Takahiro Ito

H-Index: 11

Timothy Owen
Timothy Owen

H-Index: 6

Alessandro Parente
Alessandro Parente

H-Index: 26

Markus Selzner
Markus Selzner

H-Index: 36

Scott Alford
Scott Alford

H-Index: 4

Abbas Rana
Abbas Rana

H-Index: 26

Paolo Magistri
Paolo Magistri

H-Index: 16

Fabrizio Di Benedetto
Fabrizio Di Benedetto

H-Index: 23

Bethany Johnson
Bethany Johnson

H-Index: 5

Philipp Dutkowski
Philipp Dutkowski

H-Index: 37

LUSTRE: a phase III randomized trial of stereotactic body radiotherapy (SBRT) vs. conventionally hypofractionated radiotherapy (CRT) for medically inoperable stage I non-small …

International Journal of Radiation Oncology, Biology, Physics

2022/12/1

Combination Intravenous Immune Globulin (IVIG) and High Dose Steroids for Treatment of Immune-Related Myelitis in a Non-Small Cell Lung Cancer Patient Treated With …

Clinical Lung Cancer

2022/12/1

Timothy Owen
Timothy Owen

H-Index: 6

Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial

Clinical and Translational Radiation Oncology

2022/11/1

Sameer Parpia
Sameer Parpia

H-Index: 19

Sergio Faria
Sergio Faria

H-Index: 4

Timothy Owen
Timothy Owen

H-Index: 6

Harold Lau
Harold Lau

H-Index: 21

Robert Thompson
Robert Thompson

H-Index: 10

Outcomes of hypofractionated stereotactic radiotherapy for small and moderate-sized brain metastases: a single-institution analysis

Frontiers in Oncology

2022/4/4

A comparison of hypofractionated and twice-daily thoracic irradiation in limited-stage small-cell lung cancer: an overlap-weighted analysis

Cancers

2021/6/9

Noah Greifer
Noah Greifer

H-Index: 3

Jessica Weiss
Jessica Weiss

H-Index: 5

Alexander Sun
Alexander Sun

H-Index: 5

Timothy Owen
Timothy Owen

H-Index: 6

Andrew Robinson
Andrew Robinson

H-Index: 23

Geoffrey Liu
Geoffrey Liu

H-Index: 4

The economic burden of postoperative complications predicted by the Comprehensive Complication Index® in patients undergoing elective major hepatopancreaticobiliary surgery for …

in vivo

2021/3/1

Nikolaos Machairas
Nikolaos Machairas

H-Index: 17

Timothy Owen
Timothy Owen

H-Index: 6

How to handle arterial conduits in liver transplantation? Evidence from the first multicenter risk analysis

Annals of surgery

2021/12/1

Joseph Dinorcia
Joseph Dinorcia

H-Index: 15

Timothy Owen
Timothy Owen

H-Index: 6

Elias Khajeh
Elias Khajeh

H-Index: 12

Philipp Dutkowski
Philipp Dutkowski

H-Index: 37

See List of Professors in Timothy Owen University(Queens University)